Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction

dc.contributor.author	F. Abdel Rahman, Mohamed
dc.contributor.author	M. Hashad, Ingy
dc.contributor.author	Abou-Aisha, Khaled
dc.contributor.author	M. Abdel-Maksoud, Sahar
dc.contributor.author	Z. Gad, Mohamed
dc.date.accessioned	2020-01-23T09:18:44Z
dc.date.available	2020-01-23T09:18:44Z
dc.date.issued	2015
dc.description	MSA Google Scholar	en_US
dc.description.abstract	The enzyme paraoxonase-1 (PON1) represents an endogenous defense mechanism against vascular oxidative stress, thereby contributing to the prevention of atherosclerosis. Several polymorphisms have been reported in the PON1 gene, including Q192R. PON1 phenotype is commonly expressed as the paraoxonase/arylesterase ratio (PON/ARE). The major aim of this study was
dc.title	Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction
dc.type	Article
dc.Affiliation	October University for modern sciences and Arts (MSA)